TrialAmerican journal of clinical dermatology2026

Itch Relief and Quality-of-Life Improvement with Abrocitinib and Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE COMPARE and JADE DARE.

Gil Yosipovitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.